Medpace CEO August J. Troendle disposes of USD 44.42 million in common shares
Bitget2026/09/23 20:06- Medpace CEO and President August J. Troendle sold 70,901 common shares on Sept. 21-22, SEC filing shows.
- Sales priced at USD 623.29 per share on Sept. 21, USD 628.11 per share on Sept. 22.
- Directly held stake fell to 433,372 shares following the transactions.
- Troendle also reported 4.73 million shares held indirectly through Medpace Investors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
White House National Economic Council Director Hassett questions the necessity of Fed rate hikes and criticizes some officials for advocating further tightening policies.
A senior economic official from the White House publicly questioned the necessity of the recent interest rate hikes by the Federal Reserve on Wednesday.
The wave of US Treasury sell-off continues! The largest long-term US Treasury ETF falls to its lowest level in over 20 years, dropping by half from its 2020 peak.
The U.S. long-term Treasury bond market continues to face pressure, with the largest exchange-traded fund tracking long-term U.S. Treasuries closing at its lowest level in over 20 years on Wednesday.

BUZZ-MGM Resorts shares fall after People Inc. withdraws acquisition offer